Zobrazeno 1 - 10
of 252
pro vyhledávání: '"anti-angiogenesis therapy"'
Autor:
Ying Chen, Zhiyong Zhang, Fan Pan, Pengfei Li, Weiping Yao, Yuxi Chen, Lei Xiong, Tingting Wang, Yan Li, Guichun Huang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-19 (2024)
Abstract Background It has been proposed that anti-angiogenesis therapy could induce tumor "vascular normalization" and further enhance the efficacy of chemotherapy, radiotherapy, target therapy, and immunotherapy for nearly twenty years. However, th
Externí odkaz:
https://doaj.org/article/5171f8cc8b1046688c67ff382a0e201d
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
To date, despite extensive research, the prognosis of advanced osteosarcoma has not improved significantly. Thus, patients experience a reduced survival rate, suggesting that a reevaluation of current treatment strategies is required. Recently, in ad
Externí odkaz:
https://doaj.org/article/48569f3ba250405896e2c85ca2a2a46d
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Angiogenesis is essential for tumour growth and metastasis. Antiangiogenic factor-targeting drugs have been approved as first line agents in a variety of oncology treatments. Clinical drugs frequently target the VEGF signalling pathway during sprouti
Externí odkaz:
https://doaj.org/article/482ed06ce5604246b966237775aab981
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide every year, and most HCC patients are diagnosed with advanced disease and can only receive systemic treatment. TKIs are the most importa
Externí odkaz:
https://doaj.org/article/323bfbde9e90432080b00bd8cf30739c
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Tumor immunotherapy, as the focus of scientific research and clinical tumor treatment in recent years, has received extensive attention. Due to its remarkable curative effect and fewer side effects than traditional treatments, it has significant clin
Externí odkaz:
https://doaj.org/article/a68bda94626a47d4a218e7f6b8d38e09
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Judi Xu, Hedai Liu, Guoying Ni, Yan Huang, Ying Huang, Hongxiang Liang, Yufeng Ni, Qian Huang, Zhiyong Yang
Publikováno v:
Frontiers in Surgery, Vol 10 (2023)
A 54-year-old male was diagnosed with extensive liver metastasis and small nodule metastasis in the lungs from gastric adenocarcinoma [Her-2 (−)]. The patient achieved significant partial response (PR) after chemotherapy combined with anti-angiogen
Externí odkaz:
https://doaj.org/article/31c8c0c01b8d4c03b8f58342bc08a519
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundHalf of the population of non-small cell lung cancer (NSCLC) patients are older than 70 years and have limited therapeutic options due to poor tolerance and being excluded in most clinical trials. Anlotinib hydrochloride, a novel oral multi
Externí odkaz:
https://doaj.org/article/a17dae1199f44e21b98202c868c75f65
Publikováno v:
Waike lilun yu shijian, Vol 27, Iss 02, Pp 152-157 (2022)
Objective To compare hepatic artery infusion chemotherapy (HAIC) with transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma combined with both anti-angiogenesis and immunotherapy for effectiveness and safety. Me
Externí odkaz:
https://doaj.org/article/622fbc777e804a8598cc7e13c8a5a1a6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.